Skip to content

Clinical Study on Tendon Needle Therapy Combined with Platelet-Rich Plasma Precise Injection for Mild to Moderate Rotator Cuff Injury

Effect of Tendon Needle Therapy Combined with Precise Platelet-Rich Plasma Injection on Pain, Joint Mobility and Self-Care Ability in Patients with Mild to Moderate Rotator Cuff Injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000583
Enrollment
Unknown
Registered
2026-03-18
Start date
2024-05-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rotator cuff injury

Interventions

Group 4Kinetic Acupuncture Combined with Precise Platelet-Rich Plasma Injection Group:Basic Intervention + Kinetic Acupuncture + Precise PRP Injection
Kinetic Acupuncture + Normal Saline Injection Group: + Basic Intervention + Kinetic Acupuncture + Precise Normal Saline Injection
Kinetic Acupuncture Alone Group:Basic Intervention + Kinetic Acupuncture
Platelet-Rich Plasma Precise Injection Alone Group:Basic Intervention + Precise Platelet-Rich Plasma Injection

Sponsors

The Sixth Medical Center of Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Adult patients aged 30–70 years.(2) Diagnosed with mild-to-moderate rotator cuff injury by clinical and imaging examinations, Neer grade I–II.(3) Shoulder pain duration =3 months and <24 months.(4) Poor response to conservative treatment.(5) Visual Analogue Scale (VAS) score =4.(6) Partial rotator cuff injury shown on MRI or ultrasound,isolated partial tear of the supraspinatus tendon,thickness <50% and length <3 cm,excluding composite injury of multiple tendons.(7) Conscious and able to understand and cooperate with all assessments.

Exclusion criteria

Exclusion criteria: 1.Patients with complete rotator cuff tear of the shoulder joint, biceps tendon rupture, or combined with subacromial impingement syndrome. 2.Patients with a history of shoulder surgery, tendon needle therapy, or intra-articular injection therapy within the past 6 months. 3.Patients with infection, malignant tumor, or tuberculous lesions in the shoulder. 4.Patients with coagulation dysfunction, or taking anticoagulant drugs, or with a platelet count < 100×10^9/L. 5.Pregnant or lactating women. 6.Patients with severe heart, liver, or renal insufficiency, or complicated with hematological diseases or systemic autoimmune diseases. 7.Patients with mental illness, or unable to cooperate with the completion of treatment and evaluation. 8.Patients with a history of allergy to local anesthetics. 9.Patients who have recently used steroids locally in the shoulder.

Design outcomes

Primary

MeasureTime frame
Pain intensity;Shoulder ROM;Activities of Daily Living;

Secondary

MeasureTime frame
Shoulder Joint Function;Imaging Evaluation;Patient Satisfaction;

Countries

china

Contacts

Public Contactfubensheng

The Sixth Medical Center of Chinese PLA General Hospital

FBS051625@163.com18627872086

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026